Table 2 General features of the included studies
Studies | Trial name | Study type | Region | Randomization period (year) | Patients in CABG group (n) | Patients in PCI group (n) |
|---|---|---|---|---|---|---|
Banning (2010) | SYNTAX | RCT | England | – | 88 | 88 |
Bari (1997) | BARI | RCT | Pittsburgh | 1988–1991 | 47 | 45 |
Dangas (2014) | FREEDOM | RCT | New York | 2005–2010 | 277 | 325 |
Detre (1999) | BARI | RCT | Pittsburgh | 1988–1991 | 80 | 78 |
Farkouh (2012) | FREEDOM | RCT | New York | 2005–2010 | 293 | 322 |
Kamalesh (2013) | – | RCT | Indiana | 2006–2010 | 45 | 48 |
Kappetein (2013) | SYNTAX | RCT | Netherlands | – | 93 | 89 |
Kapur (2010) | CARDIa | RCT | England | – | 99 | 88 |
Lima (2013) | MASS II | RCT | Brazil | 1995–2000 | 29 | 30 |
Soares (2006) | MASS II | RCT | Brazil | 1995–2000 | 23 | 19 |